Cited by 761Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAdipose Tissue and Metabolism

Minireview: Adiposity, Inflammation, and Atherogenesis

Lyon, Christopher J., Law, Ronald E., Hsueh, Willa A.·2003·Endocrinology

Abstract

Adipose tissue is a dynamic endocrine organ that secretes a number of factors that are increasingly recognized to contribute to systemic and vascular inflammation. Several of these factors, collectively referred to as adipokines, have now been shown regulate, directly or indirectly, a number of the processes that contribute to the development of atherosclerosis, including hypertension, endothelial dysfunction, insulin resistance, and vascular remodeling. Several adipokines are preferentially expressed in visceral adipose tissue, and the secretion of proinflammatory adipokines is elevated with increasing adiposity. Not surprisingly, approaches that reduce adipose tissue depots, including surgical fat removal, exercise, and reduced caloric intake, improve proinflammatory adipokine levels and reduce the severity of their resultant pathologies. Systemic adipokine levels can also be favorably altered by treatment with several of the existing drug classes used to treat insulin resistance, hypertension, and hypercholesterolemia. Greater understanding of adipokine regulation, however, should result in the design of improved treatment strategies to control disease states associated with increase adiposity, an important outcome in view of the growing worldwide epidemic of obesity.

Integrity signals

Registry

Crossref · 10.1210/en.2003-0285

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher aortic pulse-wave velocity, a measure of aortic stiffness, strongly correlates with increases in BMI, waist circumference and waist-hip ratio independent of systolic blood pressure, race, and sex.

    “Moreover, higher aortic pulse-wave velocity, a measure of aortic stiffness, strongly correlates with increases in BMI, waist circumference and waist-hip ratio independent of systolic blood pressure, race, and sex19,20.”
  • Excess visceral fat is an important source of cytokines and other factors that create a milieu of oxidative stress and inflammation that contributes to endothelial dysfunction, vascular stiffening, and eventually atherosclerosis.

    “There is evidence that excess visceral fat is an important source of cytokines and other factors that create a milieu of oxidative stress and inflammation that contributes to endothelial dysfunction, vascular stiffening, and eventually atherosclerosis20.”
  • White adipose tissue contributes to systemic inflammation by producing biomolecules, including pro-inflammatory mediators, whose synthesis is altered along with expansion of the adipose tissue.

    “White adipose tissue (WAT), now considered as a pivotal endocrine organ, contributes to the systemic inflammation by producing biomolecules, including pro-inflammatory mediators, whose estimated number grows constantly and whose synthesis is altered along with the expansion of the adipose tissue [6,7].”

Cites

Flagged first, then by citations

1 of the 121 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lyon, C. J., Law, R. E., & Hsueh, W. A.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Hsueh, Willa A.
Venue
Endocrinology
Published
2003-06-01
Volume
144
Issue
6
Pages
2195-2200
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W1981444005
Cited by
761
References
121
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 15 · 2021: 12 · 2020: 16 · 2019: 42 · 2018: 23 · 2017: 31 · 2016: 20 · 2015: 39 · 2014: 31 · 2013: 31 · 2012: 37
FWCI
9.73
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (1P01 HIG0030-01A1)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiposity, adipokines, atherosclerosis, vascular inflammation, visceral adipose tissue, obesity, insulin resistance, hypertension, endothelial dysfunction, vascular remodeling, bariatric surgery, physical activity, caloric restriction, anti-inflammatory agents, hypercholesterolemia
MeSH terms
Adipose Tissue, Animals, Arteriosclerosis, Humans, Obesity, Vasculitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review